Logo

American Heart Association

  7
  0


Final ID:

Discussant: PROMPT AF

  • Sarkozy, Andrea  ( UNIVERSITY HOSPITAL Brussels , Brussels , Belgium )
  • Verma, Atul  ( McGill University Health Centre , Montreal , Quebec , Canada )
  • Piccini, Jonathan  ( DUKE UNIVERSITY MEDICAL CENTER , Durham , North Carolina , United States )
  • Author Disclosures:
    Andrea Sarkozy: DO have relevant financial relationships ; Consultant:Biosense Webster:Active (exists now) ; Speaker:Pfizer:Past (completed) ; Speaker:microport:Past (completed) ; Speaker:biotronik:Active (exists now) ; Consultant:Medtronic:Active (exists now) | Atul Verma: No Answer | Jonathan Piccini: DO have relevant financial relationships ; Consultant:Abbott:Active (exists now) ; Consultant:Sanofi:Active (exists now) ; Consultant:Medtronic:Active (exists now) ; Research Funding (PI or named investigator):Phillips:Active (exists now) ; Research Funding (PI or named investigator):iRhythm:Active (exists now) ; Other (please indicate in the box next to the company name):Kardium:Active (exists now) ; Consultant:Milestone:Active (exists now) ; Consultant:ABVF:Active (exists now) ; Research Funding (PI or named investigator):American Heart Association:Active (exists now) ; Research Funding (PI or named investigator):Boston Scientific:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Revolutionizing AF Management: Cutting-Edge Approaches

Monday, 11/18/2024 , 09:45AM - 11:00AM

Late-Breaking Science

More abstracts on this topic:
Aggressive Risk factor REduction STudy for Atrial Fibrillation (ARREST-AF) implications for ablation outcomes: A Randomized Clinical Trial

Pathak Rajeev, Mahajan Rajiv, Abhayaratna Walter, Kalman Jonathan, Sanders Prashanthan, Elliott Adrian, Lau Dennis, Middeldorp Melissa, Linz Dominik, Fitzgerald John, Ariyaratnam Jonathan, Malik Varun, Noubiap Jean Jacques

Randomized Controlled Trial of Metformin and Lifestyle/Risk Factor Modification for Upstream Prevention of Atrial Fibrillation Progression: The Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF) Trial

Chung Mina, Cantlay Catherine, Crookshanks Michael, Mchale Megan, Lovano Beth, Castel Laurie, Park Kevin, Foster Parker, Guo Lydia, Yang Lucy, Sullivan Erin, Wass Sojin, Jin Alison, Cantlay Paul, Varma Niraj, Barzilai Benico, Bruemmer Dennis, Cho Leslie, Huang Julie, Hussein Ayman, Kashyap Sangeeta, Xlaffinx Xlukex, Sun Han, Mehra Reena, Moravec Christine, Saliba Walid, Wazni Oussama, Sanders Prashanthan, Nissen Steven, Van Iterson Erik, Smith Jonathan, Van Wagoner David, Barnard John, Kim Hyun Su, Schilling Taylor, Telfer William, Lissemore Frances, Bibidakis Dimitra, Lin Cheryl

More abstracts from these authors:
Coffee and Calesthenics: AF Risk Factor Modification - Where do we stand?

Sanders Prashanthan, Marcus Gregory, Piccini Jonathan

The Earlybird Gets the Worm: AF in Heart Failure - Is Earlier is Better?

Gopinathannair Rakesh, Piccini Jonathan

You have to be authorized to contact abstract author. Please, Login
Not Available